$ADUS

Addus HomeCare Announces Third Quarter 2026 Financial Results

Addus HomeCare reported Q3 2026 net service revenues of $387.7M, up 7.0%, with net income of $28.6M ($1.54 per diluted share). Adjusted net income per share rose 17.3% YoY to $1.83. The company announced a deal to acquire AccentCare's personal care division for ~$100M. As of Q3 2026, cash on hand was $40.9M. Management highlighted strong growth in personal care and hospice segments. A conference call is scheduled for November 4, 2026.

Original reporting
Published Nov 3, 2026, 9:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ADUS
Bullish
high confidence
Mentioned
$ADUS
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ADUSBullishMed
01

Why it matters

The earnings release and acquisition announcement together provide fresh material for traders to reassess valuation and growth prospects.

02

Market read

First‑time Q3 2026 earnings and a strategic acquisition create a clear catalyst for ADUS, offering a medium‑term trading opportunity.

03

What to watch

Potential regulatory scrutiny of the acquisition and the company's reliance on Medicare reimbursement rates.

Relevance 7/10Novelty 7/10Timing: post‑release today

Background

Addus HomeCare is a NASDAQ‑listed provider of home‑care services. The company announced a strategic acquisition to expand its personal‑care footprint.

Company-level read

Ticker impact

$ADUSBullishHigh confidence
Context

Addus HomeCare reported Q3 2026 results with 7% revenue growth, $28.6M net income and announced a definitive agreement to acquire AccentCare's personal care division.

Expected impact

potential modest upside as investors price in revenue growth and acquisition synergies

Evidence & confidence

First‑time disclosure of quarterly numbers and a material acquisition; market typically reacts positively to beat‑and‑buy signals.

Market effects

Home‑care and senior‑services sector may see increased investor interest due to Addus' growth and acquisition activity.

U.S. healthcare services market could experience modest buying pressure from the news.

Limited to U.S. healthcare equities; no broader macro impact.

Counterpoint

If integration costs of the AccentCare acquisition exceed expectations, the stock could face pressure despite earnings beat.

Key entities

  • Addus HomeCare Inc.

    NASDAQ: ADUS, provider of home‑care services.

  • AccentCare

    Target of Addus' personal‑care division acquisition.

Related articles

$ADUSMed

Addus HomeCare Q3 Earnings Call Highlights

Addus HomeCare (ADUS) reported Q3 revenue of $389.7M, with personal care services generating $301M (77.6%). Same-store personal care revenue grew 6.9% YoY. The company expects to improve EBITDA margins through synergies from the AccentCare acquisition. Addus plans to fund the acquisition with cash and revolving credit. Hospice revenue rose 4.1%, and home health revenue increased 2.5%. Management anticipates modest EBITDA margin decline in 2027 due to the AccentCare deal.

$ADUSMedAI 8/10

Why is Addus HomeCare stock sliding today?

Addus HomeCare (ADUS) shares fell 3.6% premarket after mixed Q3 results: EPS beat $1.83 vs. $1.79 estimate, but revenue missed $387.7M vs. $388.7M. BofA downgraded to Neutral, cutting PT to $125 from $140. Company announced $275M acquisition of AccentCare's personal care ops. S&P 500 and Dow Jones rose 1.1% and 2.1% respectively.

$ADUSMedAI 8/10

Addus HomeCare falls on revenue miss despite earnings beat

Addus HomeCare (ADUS) reported Q3 earnings of $1.83 per share, beating estimates by $0.04, but revenue of $387.7M missed expectations. Revenue grew 7% YoY, and adjusted EBITDA rose 13.5%. The company plans to acquire AccentCare's personal care division for $275M, expecting $280M in annualized revenue. Shares fell 2.6% in after-hours trading.